Search

everythinglearnresearchcommunity

for

Search:↓

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Mogamulizumab can cause hair loss and skin rashes.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

MK-5108 is safe and shows potential against tumors, especially alone.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

Dupilumab improves skin microbiome balance in atopic dermatitis patients.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

Mettl3 is essential for normal tissue development and self-renewal by regulating gene expression.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.